M&T Bank Corp Purchases 52,458 Shares of Prestige Consumer Healthcare Inc. $PBH

Key Points

• M&T Bank Corp bought 52,458 shares in Q4, boosting its stake by 1,397.8% to 56,211 shares — roughly a $3.47 million position, or about 0.12% of Prestige Consumer Healthcare.
• Prestige missed Q4 estimates with $1.14 EPS (vs. $1.16 expected) and revenue fell 2.4% year-over-year; the company set FY2026 guidance at 4.54 EPS, which matches current analyst expectations.
• Institutional ownership is extremely high at 99.95%, with large recent buys from the likes of Goldman Sachs (+120,965 shares) and Jane Street (+70,330 shares), while analysts maintain a consensus Hold rating and an average price target of $76.50.

M&T Bank Corp grew its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 1,397.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 56,211 shares of the company's stock after purchasing an additional 52,458 shares during the quarter. M&T Bank Corp owned about 0.12% of Prestige Consumer Healthcare worth $3,468,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. AQR Capital Management LLC grew its holdings in Prestige Consumer Healthcare by 11.9% in the 1st quarter. AQR Capital Management LLC now owns 30,056 shares of the company's stock valued at $2,558,000 after buying an additional 3,200 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Prestige Consumer Healthcare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,490 shares of the company's stock worth $2,535,000 after buying an additional 1,289 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Prestige Consumer Healthcare by 28.4% during the first quarter. Goldman Sachs Group Inc. now owns 546,672 shares of the company's stock worth $46,997,000 after buying an additional 120,965 shares during the last quarter. Jane Street Group LLC boosted its position in shares of Prestige Consumer Healthcare by 204.0% in the first quarter. Jane Street Group LLC now owns 104,802 shares of the company's stock valued at $9,010,000 after acquiring an additional 70,330 shares during the period. Finally, Geneos Wealth Management Inc. boosted its position in shares of Prestige Consumer Healthcare by 92.8% in the first quarter. Geneos Wealth Management Inc. now owns 559 shares of the company's stock valued at $48,000 after acquiring an additional 269 shares during the period. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Trading Up 0.0%

Shares of Prestige Consumer Healthcare stock opened at $58.97 on Monday. The firm has a market capitalization of $2.79 billion, a PE ratio of 15.60, a price-to-earnings-growth ratio of 1.76 and a beta of 0.47. The company has a debt-to-equity ratio of 0.58, a current ratio of 3.11 and a quick ratio of 1.93. The company's fifty day moving average price is $61.89 and its two-hundred day moving average price is $62.19. Prestige Consumer Healthcare Inc. has a 52-week low of $51.24 and a 52-week high of $89.37.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, February 5th. The company reported $1.14 earnings per share for the quarter, missing the consensus estimate of $1.16 by ($0.02). The business had revenue of $283.44 million for the quarter, compared to analyst estimates of $286.93 million. Prestige Consumer Healthcare had a net margin of 16.90% and a return on equity of 12.02%. Prestige Consumer Healthcare's revenue was down 2.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.22 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.540-4.540 EPS. On average, analysts expect that Prestige Consumer Healthcare Inc. will post 4.54 EPS for the current year.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, VP Jeffrey Zerillo sold 1,000 shares of the company's stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $65.93, for a total value of $65,930.00. Following the sale, the vice president directly owned 41,048 shares in the company, valued at $2,706,294.64. This represents a 2.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.40% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

PBH has been the topic of a number of research reports. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Prestige Consumer Healthcare in a research report on Tuesday, April 21st. Jefferies Financial Group reduced their price target on shares of Prestige Consumer Healthcare from $70.00 to $66.00 and set a "hold" rating for the company in a report on Friday, January 30th. Three analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $76.50.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare, Inc is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women's health.

Key brands in Prestige's portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women's health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy).

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.